Unlocking insulin access for millions worldwide
Access to groundbreaking medicines is meaningless without real patient access. In our journey spanning over 50 years, we've advanced our science and manufacturing to supply insulin to nearly 30 million people. Yet, the urgency for patients with type two diabetes and obesity is palpablethey can't afford to wait another half-century.…